IPV ¹é½Å ½ÃÀå : ¹é½Å ºê·£µåº°, À¯Åë ä³Îº°, Áö¿ªº° - ½ÃÀå ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2024-2031³â)
IPV Vaccines Market, by Vaccine Brand (POLIOVAC, SHANIPV, POLIORIX, IPOL/IMOVAX, And POLYMILEX), by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
»óǰÄÚµå : 1461449
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,354,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,884,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,120,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ IPV ¹é½Å ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 1¾ï 9,960¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ Áß(2024-2031³â) CAGRÀº 8.5%·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ´ë»ó ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2023³â ½ÃÀå ±Ô¸ð(2023³â, 2024³â) 1¾ï 9,960¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø±â°£(2023³â, 2024-2030³â, 2031³â) CAGR 8.50% ¿¹ÃøÄ¡(2030³â, 2031³â) 3¾ï 5,240¸¸ ´Þ·¯
¼¼°èÀÇ IPV ¹é½Å ½ÃÀå Áö¿ªº° ±Ô¸ð(USD Mn)(2024³â)
IPV Vaccines Market-IMG1

ºÒȰ¼ºÈ­µÈ Æú¸®¿À ¹é½Å(IPV)Àº ¼ÒÅ© ¹é½ÅÀ¸·Îµµ ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. Æú¸®¿À ¹é½Å¿¡´Â ºÒȰ¼ºÈ­ Æú¸®¿À ¹é½Å°ú °æ±¸ Æú¸®¿À ¹é½ÅÀÇ µÎ °¡Áö À¯ÇüÀÌ ÀÖ½À´Ï´Ù. IPV ¹é½ÅÀº ÁÖ·Î ÆÈ°ú ´Ù¸®¿¡ ÁÖ»çÇÕ´Ï´Ù.

°è¶õÀ̳ª ½ºÆ®·¾Å丶À̽Űú °°Àº ¾à¹°¿¡ ¾Ë·¹¸£±â°¡ ÀÖ´Â »ç¶÷Àº IPV Áֻ縦 ¹Þ¾Æ¼­´Â ¾ÈµË´Ï´Ù. IPV´Â ¿¹¹æÁ¢Á¾À» ¹Þ´Â »ç¶÷ÀÌ Àå±â°£ ½ºÅ×·ÎÀÌµå ¿ä¹ýÀ» ¹Þ°í ÀÖ´Â °æ¿ì, ¾ÏÀ» ¾Î°í ÀÖ´Â °æ¿ì, È­Çпä¹ýÀ» °è¼ÓÇÏ´Â °æ¿ì, ¶Ç´Â Áý¿¡ ¸é¿ªÀÌ ¾ø´Â ¼ºÀÎÀÌ ÀÖ´Â °æ¿ì¿¡¸¸ Á¢Á¾µË´Ï´Ù.

¼¼°èÀÇ IPV ¹é½Å ½ÃÀåÀº 2024³â¿¡´Â 1¾ï 9,960¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2031³â¿¡´Â 3¾ï 5,240¸¸ ´Þ·¯·Î È®´ëµÉ Àü¸ÁÀ̸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 8.5%°¡ µÉ Àü¸ÁÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼Ò¾Æ¸¶ºñÀÇ ¹ß»ýÀ» ¸·±â À§ÇØ ´Ù¾çÇÑ Á¤ºÎ°¡ ¿¹¹æÁ¢Á¾¿¡ ´ëÇÑ ÀǽÄÀ» ³ôÀ̱â À§ÇÑ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃëÇϰí ÀÖ½À´Ï´Ù. °ø°ø±â°üÀº °¡³­ÇÑ »ç¶÷µé¿¡°Ô ¹é½Å Á¢Á¾À» Á¦°øÇϱâ À§ÇØ À¯ÀÍÇÑ ¿¹¹æ Á¢Á¾ ÇÁ·Î±×·¥À» µµÀÔÇϰí, À̰ÍÀº °¡±î¿î ¹Ì·¡¿¡ ¼¼°èÀÇ ºÒȰȭ Æú¸®¿À ¹é½Å(IPV) ½ÃÀåÀÇ ¼ºÀåÀ» À§ÇÑ ¸Å¿ì Á¶ÀåÀûÀΠȯ°æÀ» ¸¸µé °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2019³â 9¿ù, °¡³ª º¸°Ç ¼­ºñ½º(GHS)´Â °íÀ§Çè Áö¿ª¿¡¼­ ¹ÙÀÌ·¯½º È®»êÀ» ¹æÁöÇϱâ À§ÇØ ÀÏ·ÃÀÇ Æú¸®¿À ¹é½Å Á¢Á¾ ¹× ¿¹¹æ Á¢Á¾ Ä·ÆäÀÎÀ» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ¿¹¹æÁ¢Á¾ Æú¸®¿À ¹é½Å Ä·ÆäÀο¡¼­´Â ºÒȰȭ Æú¸®¿À ¹é½Å(IPV)À» ÀÌ¿ëÇØ, °¡³ª ÀüÅäÀÇ Àü Áö±¸¿¡¼­ 2016³â 1¿ùºÎÅÍ 2018³â 6¿ù±îÁö ž ¸ðµç ¾ÆÀÌ¿¡°Ô ¿¹¹æ Á¢Á¾À» ½Ç½ÃÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå Áß¿äÇÑ ÀλçÀÌÆ®

Á¦4Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå : ¹é½Å ºê·£µåº°(2019-2031³â)

Á¦5Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå : ¹é½Å À¯Çüº°(2019-2031³â)

Á¦6Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå : ¹ÙÀÌ¾Ë À¯Çüº°(2019-2031³â)

Á¦7Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå : À¯Åë ä³Îº°(2019-2031³â)

Á¦8Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå : Áö¿ªº°(2019-2031³â)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ-¼¼°èÀÇ IPV ¹é½Å ½ÃÀå

Á¦11Àå Âü°í ¹®Çå ¹× Á¶»ç ¹æ¹ý

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global IPV vaccines market is estimated to be valued at USD 199.6 Mn in 2024 and is expected to exhibit a CAGR of 8.5% during the forecast period (2024-2031).

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 199.6 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 8.50% 2030/2031 Value Projection: US$ 352.4 Mn
Global IPV Vaccines Market Value (USD Mn), by Region, 2024
IPV Vaccines Market - IMG1

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 199.6 Mn in 2024 and is expected to increase to US$ 352.4 Mn by 2031, registering a CAGR of 8.5% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2019, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Key Insights

4. Global IPV Vaccines Market, By Vaccine Brand, 2019 - 2031 (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2019 - 2031 (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2019 - 2031 (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2019 - 2031 (US$ Million)

8. Global IPV Vaccines Market, By Region, 2019 - 2031 (US$ Million)

9. Competitive Landscape

10. Company Profiles - Global IPV Vaccines Market

11. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â